Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Clinical trial NCT04498117 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04498117
Sponsor: CanariaBio Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Ovarian Epithelial Ovarian Neoplasms Ovarian Cancer Ovarian Serous Adenocarcinoma Fallopian Tube Neoplasms Fallopian Tube Adenocarcinoma Fallopian Tube Serous Adenocarcinoma Peritoneal Cancer Peritoneal Carcinoma Peritoneal Neoplasms

Start date: 2020-08-25
Primary completion: 2026-12-26
Enrollment: 615

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.